Shushan A - Search Results

1

The Rising Phoenix-Progesterone as the Main Target of the Medical Therapy for Leiomyoma.

Chill HH, Safrai M, Reuveni Salzman A, Shushan A. Chill HH, et al. Among authors: shushan a. Biomed Res Int. 2017;2017:4705164. doi: 10.1155/2017/4705164. Epub 2017 Sep 13. Biomed Res Int. 2017. PMID: 29312996 Free PMC article. Review.

2

Selective Progesterone Receptor Modulators for the Treatment of Uterine Leiomyomas.

Safrai M, Chill HH, Reuveni Salzman A, Shushan A. Safrai M, et al. Among authors: shushan a. Obstet Gynecol. 2017 Aug;130(2):315-318. doi: 10.1097/AOG.0000000000002143. Obstet Gynecol. 2017. PMID: 28697115

3

Growth pattern of uterine leiomyoma along pregnancy.

Chill HH, Karavani G, Rachmani T, Dior U, Tadmor O, Shushan A. Chill HH, et al. Among authors: shushan a. BMC Womens Health. 2019 Jul 22;19(1):100. doi: 10.1186/s12905-019-0803-5. BMC Womens Health. 2019. PMID: 31331317 Free PMC article.

4

Reproductive and obstetric outcomes following operative hysteroscopy for treatment of retained products of conception.

Chill HH, Safrai M, Karavani G, Cohen A, Alexandroni H, Bahar R, Shushan A. Chill HH, et al. Among authors: shushan a. Minerva Obstet Gynecol. 2021 Aug;73(4):494-499. doi: 10.23736/S2724-606X.21.04761-4. Minerva Obstet Gynecol. 2021. PMID: 34319060

5

Operative hysteroscopy for treatment of intrauterine pathologies does not interfere with later endometrial development in patients undergoing in vitro fertilization.

Kogan L, Dior U, Chill HH, Karavani G, Revel A, Shushan A, Simon A. Kogan L, et al. Among authors: shushan a. Arch Gynecol Obstet. 2016 May;293(5):1097-100. doi: 10.1007/s00404-015-3988-3. Epub 2015 Dec 16. Arch Gynecol Obstet. 2016. PMID: 26676830

6

Reducing Fluid-Related Complications During Operative Hysteroscopy: Use of a New Mandatory Fluid-Balance Form.

Alexandroni H, Bahar R, Chill HH, Karavani G, Ben-Yossef O, Shushan A. Alexandroni H, et al. Among authors: shushan a. J Minim Invasive Gynecol. 2017 Sep-Oct;24(6):1014-1019. doi: 10.1016/j.jmig.2017.06.014. Epub 2017 Jun 22. J Minim Invasive Gynecol. 2017. PMID: 28648840

7

Risk factors for recurrent Pelvic Inflammatory Disease.

Safrai M, Rottenstreich A, Shushan A, Gilad R, Benshushan A, Levin G. Safrai M, et al. Among authors: shushan a. Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:40-44. doi: 10.1016/j.ejogrb.2019.11.004. Epub 2019 Nov 7. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31734623

8

Intraoperative Ultrasound Guidance During Curettage After Second-Trimester Delivery is Associated With a Higher Rate of Complications.

Levin G, Safrai M, Dior UP, Gilad R, Benshushan A, Shushan A, Rottenstreich A. Levin G, et al. Among authors: shushan a. J Obstet Gynaecol Can. 2020 Sep;42(9):1080-1085. doi: 10.1016/j.jogc.2020.02.115. Epub 2020 Apr 25. J Obstet Gynaecol Can. 2020. PMID: 32345554

9

The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth.

Shushan A, Rojansky N, Laufer N, Klein BY, Shlomai Z, Levitzki R, Hartzstark Z, Ben-Bassat H. Shushan A, et al. Hum Reprod. 2004 Sep;19(9):1957-67. doi: 10.1093/humrep/deh355. Epub 2004 Jun 17. Hum Reprod. 2004. PMID: 15205403

10

Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050.

Shushan A, Ben-Bassat H, Mishani E, Laufer N, Klein BY, Rojansky N. Shushan A, et al. Fertil Steril. 2007 Jan;87(1):127-35. doi: 10.1016/j.fertnstert.2006.05.056. Epub 2006 Oct 30. Fertil Steril. 2007. PMID: 17074332 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters